Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
215
datasets available to search
ShareScore release 0.9.0
Dataset results
215 results for “LEO”
Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris
ClinicalTrials.gov study NCT02310646. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT05117060. IPD Sharing: YES. Countries: 8. Publications: 0.
Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris
ClinicalTrials.gov study NCT03806790. IPD Sharing: NO. Countries: 1. Publications: 0.
LEO 90105 Ointment in Japanese Subjects With Psoriasis
ClinicalTrials.gov study NCT01422434. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis
ClinicalTrials.gov study NCT02387853. IPD Sharing: NO. Countries: 4. Publications: 0.
LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)
ClinicalTrials.gov study NCT01188928. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis
ClinicalTrials.gov study NCT01083758. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis Vulgaris
ClinicalTrials.gov study NCT00764751. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Doses of LEO 43204 Once Daily for Two Consecutive Days on Full Balding Scalp in Subjects With Actinic Keratosis
ClinicalTrials.gov study NCT02100813. IPD Sharing: NO. Countries: 1. Publications: 0.
LEO 124249 Ointment in the Treatment of Alopecia Areata
ClinicalTrials.gov study NCT02561585. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up
ClinicalTrials.gov study NCT02547363. IPD Sharing: NO. Countries: 1. Publications: 0.
The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris
ClinicalTrials.gov study NCT01768013. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up
ClinicalTrials.gov study NCT02549339. IPD Sharing: NO. Countries: 1. Publications: 0.
A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution for the Treatment of Psoriasis Vulgaris
ClinicalTrials.gov study NCT01116895. IPD Sharing: NO. Countries: 2. Publications: 0.
A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis
ClinicalTrials.gov study NCT05923099. IPD Sharing: NO. Countries: 11. Publications: 0.
LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis
ClinicalTrials.gov study NCT02668692. IPD Sharing: NO. Countries: 1. Publications: 0.
An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.
ClinicalTrials.gov study NCT04922021. IPD Sharing: NO. Countries: 4. Publications: 0.
Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis
ClinicalTrials.gov study NCT01120223. IPD Sharing: NO. Countries: 3. Publications: 0.
A Study Comparing LEO 80190 Ointment With Hydrocortisone Ointment, Both Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and Intertriginous Areas
ClinicalTrials.gov study NCT01007591. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up
ClinicalTrials.gov study NCT02547233. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.